Urinary tract infection. Experimental induction in rats.
D000818:Animals; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D004195:Disease Models, Animal; D007668:Kidney / Q000293:injuries / Q000382:microbiology / Q000473:pathology; D007669:Kidney Calculi / Q000382:microbiology; D008297:Male; D009268:Nalidixic Acid / Q000627:therapeutic use; D011513:Proteus mirabilis; D011704:Pyelonephritis / Q000188:drug therapy; D051381:Rats; D001743:Urinary Bladder / Q000473:pathology; D001744:Urinary Bladder Calculi / Q000382:microbiology; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000401:mortality; D014556:Urine / Q000382:microbiology
D000892:Anti-Infective Agents, Urinary; D009268:Nalidixic Acid